- US11733235utility2023Method for Evaluating Immunogenicity of Test Substance0 cites
- US11723976utility2023Methods of Administering Anti-il31a Antibody-containing Formulations0 cites
- US11718678utility2023Method for Altering Plasma Retention and Immunogenicity of Antigen-binding Molecule0 cites
- US11708186utility2023Filling Nozzle0 cites
- US11692037utility2023Anti-il-6 Receptor Antibody-containing Medicinal Composition for Preventing Post-surgical Adhesion0 cites
- US11692173utility2023Method for Inducing Differentiation of Pluripotent Stem Cells Into Hepatocytes0 cites
- US11673947utility2023Target Tissue-specific Antigen-binding Molecule0 cites
- US11667713utility2023Cytotoxicity-inducing Therapeutic Agent0 cites
- US11667720utility2023Subcutaneously Administered Anti-il-6 Receptor Antibody0 cites
- US11661579utility2023Cell Culture Method Using Amino Acid-enriched Medium0 cites
- US11649262utility2023Method for Promoting Efficiency of Purification of Fc Region-containing Polypeptide0 cites
- US11649293utility2023Method for Enhancing Humoral Immune Response0 cites
- US11633402utility2023RET Inhibitor0 cites
- US11622969utility2023Subcutaneously Administered Anti-il-6 Receptor Antibody0 cites
- US11612149utility2023Non-human Animal Having Human CD3 Gene Substituted for Endogenous CD3 Gene0 cites
- US11612562utility2023Solution Preparation Containing Stabilized Antibody0 cites
- US11608374utility2023Anti-sclerostin Antibodies and Methods of Use0 cites
- US11608508utility2023Method for Establishing Modified Host Cell0 cites
- US11597760utility2023Method of Detecting the Presence of Complement C50 cites